Fathom Therapeutics
PrivateLast Round
Series A
Apr 27, 2026
Total Funding Raised
$47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Fathom Therapeutics is a biotechnology company that uses physics-based simulations and AI to design novel drug molecules by modeling protein motion and interactions at the atomic level.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fathom Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Fathom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 27, 2026 |
Fathom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemistry VC | Series A |
| Alexandria Venture Investments | Series A |
| New York Ventures | Series A |
| Sutter Hill Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
$47M round led by Sutter Hill Ventures.
Fathom Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fathom Therapeutics's valuation, stock price, and market status.